Bacterial infections are the leading cause of disease and death worldwide; an ongoing public health problem exacerbated by slow or inaccurate diagnostics. Now NIBIB-funded scientists have engineered an inexpensive, paper-based test that can rapidly identify multiple types of bacteria.
Explore more about: Global Health
April 28, 2022
December 7, 2021
Awards will support innovative technologies to help improve maternal health around the world.
March 2, 2022
NIH-funded researchers are investigating how to use smartwatches to predict clinical test results, which could potentially serve as an early warning signal for underlying health issues.
February 8, 2022
Innovative, evidence-based strategies are needed to tackle the global burden of hypertension. The ubiquity of mobile phones in emerging economies, such as Ghana, provides a new health care delivery paradigm to improve hypertension health outcomes.
November 22, 2021
Washington University in St. Louis is joining a major international effort to advance data science, catalyze innovation and spur health discoveries across Africa. The program is supported by the National Institutes of Health’s (NIH) Common Fund, which will invest nearly $75 million over five years to fund the Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) program. Source: Washington University in St. Louis
November 3, 2021
The NIH RADx initiative today announced the launch of the When To Test Calculator for Individuals, a companion to the version for organizations introduced last winter. By responding to just a few prompts, the new individual impact calculator indicates whether a person should get a test—now or soon.
October 26, 2021
NIH is investing about $74.5 million over five years to advance data science, catalyze innovation and spur health discoveries across Africa. Under its new Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) program.
August 27, 2021
Placenta accreta spectrum (PAS) disorder is a life-threatening condition that occurs when the placenta remains attached to the uterus after childbirth. Now researchers have developed a blood test to identify this condition, enabling early intervention by high-risk pregnancy specialists.
July 29, 2021
Estimates developed by PHICOR, a public health research group, suggest that more than 40 percent of U.S. residents may not be sufficiently protected against the Delta variant. Source: New York Times. New York Times.
June 30, 2021
In a study that compares rapid antigen and laboratory PCR approaches for COVID-19 serial screening, researchers affiliated with the NIH RADx initiative reported results from 43 people infected with the virus.